Immunogenicity

-

SMi is launching its inaugural Immunogenicity Conference, taking place in London on the 14th and 15th July. This two day event is designed to enhance SMi’s portfolio of pharmaceutical conferences, especially with a growing demand for biologic therapeutics.

We ask the questions: What stimulates an immune response? How does the system cope with immunogenic compounds? And how do you screen for potential problems?

The Conference will address all these concerns and enable Clinical Immunologists, Physicians and Specialists within the field of Immunogenicity to discuss the major challenges currently being faced within the pharmaceutical industry.

The focus is on pre-clinical analysis and assessing treatments for clinical development. It will endeavour to look at the assessment of early risks in immunogenicity and the evaluation of in silico tools for determining immunogenicity. With an insight into the safety, development and validation of Monoclonal Antibodies.

Immunogenicity is a hurdle one looks to overcome and with the likes of aggregation being a factor when handling proteins, key sessions on Immunomodulation and Inducing Immunological Tolerance will enable delegates to get an understanding of how to address this and improve probability and efficacy.

From a clinical perspective, the conference will assess consideration and design of biologic therapeutics, clinical implications and review what the clinical outcomes are from using these immune modulatory approaches.

The conference will also look at, how to benefit the patient by assessing efficacy and toxicological concerns alongside the management of immunogenic responses. With regulators supposing that animal studies are not good predictors – how can predictability be shown with pre-clinical in-vitro tools?

Business Benefits:
•Grasp an understanding of Immunogenicity and gain an insight into assessing early risks
•Hear case studies on the tools for consideration being utilised for the determination of immunogenicity
•Assess major hurdles in clinical development and the implications in design of biologic therapeutics
•Enhance your understanding on how to best evaluate read outs for immune response
Conference Chairs:
•Matthew Baker, Chief Scientific Officer, Antitope
•Martin Lechmann,Development DMPK Project Leader, Roche
Key Speakers include:
•Robert Dodge, Associate Director, BMS
•Thomas Lee, Scientific Investigator, Clinical Immunology, GSK
•Ronit Mazor, Research Fellow, National Cancer Institute,National Institutes of Health
•Anne De Groot, CEO/CSO, EpiVax Inc
•Daniel Kramer, Associate Director, Project Representative NBE, Merck Serono
•Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences Inc.



PLUS TWO INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPS
A: Clinical Impact of Immunogenicity and Predictive Tools, Workshop Leader: Melody Sauerborn, Senior Expert Immunogenicity, TNO Triskelion
B: Immunogenicity of Biosimilars, Workshop Leader: John Chappell, Head of Immunoassay, CPR Pharma Services

For more information click on the event website link or contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk


Location:
Holiday Inn Regents Park
London
UK


Organizer: SMi Group Ltd

14 Jul 2014



All Upcoming Events
1 2 Next 
The 9th Annual Bioprocessing Summit21 Aug 2017
2nd International Conference on Generic Drugs and Biosimilars24 Aug 2017
14th International Conference and Exhibition on Pharmaceutical Formulations28 Aug 2017
13th Compound & Sample Management Summit28 Aug 2017
15th International Conference on Environmental Science and Technology (CEST 2017)31 Aug 2017
2nd European Prefilled Syringes Summit6 Sep 2017
World Congress on Biotherapeutics and Bioanalytical Techniques11 Sep 2017
4th International Conferences on Clinical Trails11 Sep 2017
Drug Safety Congress Europe 201712 Sep 2017
6th International Conference on Forensic Research & Technology18 Sep 2017
Phacilitate Cell & Gene Therapy Europe 201719 Sep 2017
Microbiome AgBioTech Summit 201720 Sep 2017
3rd Conference on Innovations to Advanced Clinical Research and Clinical Trials20 Sep 2017
9th Annual Pharmaceutical Analysis Conference25 Sep 2017
14th Confocal Raman Imaging Symposium25 Sep 2017
Biosimilars & Biobetters 201727 Sep 2017
6th Annual Cancer Vaccines Conference27 Sep 2017
ELRIG: Drug Discovery 20173 Oct 2017
Drug Discovery 20173 Oct 2017
7th Annual EPP Life Science Pricing Forum4 Oct 2017
3rd Drug Discovery Innovation Programme5 Oct 2017
Lab Asia 201710 Oct 2017
The 17th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2017)10 Oct 2017
Pharmaceutical Pricing and Market Access 201711 Oct 2017
4th International Conference on Past and Present Research Systems of Green Chemistry16 Oct 2017
11th World Drug Delivery Summit16 Oct 2017
Next-Generation Antibodies and Protein Analysis (2nd Edition)16 Oct 2017
6th Global Congress on Mass Spectrometry (Mass Spectra 2017)18 Oct 2017
7th Annual Orphan Drugs and Rare Diseases UK18 Oct 2017
Pain Medicine 201719 Oct 2017

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement